Open an account

Rockwell Medical

RMTI · NASDAQ

$7.23−$0.26 (−3.47%)TodayMarket closed ·
Prev close $7.49

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 157 full-time employees. The firm develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The firm operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The firm is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The firm manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Employees
157
Headquarters
Wixom, Michigan
Listed
Jan 27, 1998
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
rockwellmed.com

RMTI key statistics

Market cap
29.14M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
30.77K
Volume
12.18K
Open price
$7.51
High today
$7.48
Low today
$7.23
52 Week high
$12.90
52 Week low
$4.89

Rockwell Medical (RMTI) at a glance

As of Oct 20, 2026, Rockwell Medical (RMTI) shares are priced at $7.23, giving the company a market cap of 29.14M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $7.23 and $7.48. The current price is 0.0% above the day's low and 3.3% below its high.

Volume so far is 12.18K shares, below the average of 30.77K shares a day.

Over the past year Rockwell Medical has ranged from $4.89 to $12.90, and now sits 29% of the way up that range.

Rockwell Medical met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.34 per share against an estimate of -$0.2397.

The average analyst price target is $20.40, 182.2% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $20.40
Low
$20.20
Now
$7.23
High
$21.00

RMTI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 137.9% on average.

  1. Q3 FY24: reported $0.50 per share against an estimate of $0.102
  2. Q4 FY24: reported -$0.20 per share against an estimate of $0.204
  3. Q1 FY25: reported -$0.40 per share against an estimate of -$0.51
  4. Q2 FY25: reported -$0.50 per share against an estimate of -$0.51
  5. Q3 FY25: reported -$0.50 per share against an estimate of -$0.459
  6. Q4 FY25: reported -$0.10 per share against an estimate of $0.204
  7. Q1 FY26: reported -$0.40 per share against an estimate of -$0.255
  8. Q2 FY26: reported -$0.34 per share against an estimate of -$0.2397

RMTI news

  • Press releaseBusiness Wire

    Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026

  • Press releaseBusiness Wire

    Rockwell Medical to Exhibit at ASN Kidney Week 2026

  • Press releaseBusiness Wire

    Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production’ List

  • Press releaseBusiness Wire

    Rockwell Medical Announces Second Quarter 2026 Results

  • Press releaseBusiness Wire

    Rockwell Medical Advances Quality and Regulatory Leadership

  • Press releaseBusiness Wire

    Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

  • Press releaseBusiness Wire

    Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

  • Press releaseBusiness Wire

    Rockwell Medical Announces 1-for-10 Reverse Stock Split

Similar companies

Companies in the same industry as Rockwell Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.